ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cisatracurium Besylate Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-11O7953
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cisatracurium Besylate Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cisatracurium Besylate Injection Market Research Report 2025

Code: QYRE-Auto-11O7953
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Fresenius Kabi
Meitheal Pharmaceuticals
Pfizer Inc
Sandoz Inc
TEVA
Shanghai Hengrui Pharmaceutical
XIANJU PHARMA
Jiangsu Singchn
Shanghai Sino Biopharma

Cisatracurium Besylate Injection Market

The global market for Cisatracurium Besylate Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
 It is a nondepolarizing skeletal muscle relaxant for intravenous administration.COVID-19 has erupted in the world, and these drugs are in short supply.
North American market for Cisatracurium Besylate Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cisatracurium Besylate Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Cisatracurium Besylate Injection include AbbVie, Fresenius Kabi, Meitheal Pharmaceuticals, Pfizer, Sandoz, Teva, Shanghai Hengrui Pharmaceutical, Xianju Pharma, Jiangsu Singchn, Shanghai Sino Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cisatracurium Besylate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cisatracurium Besylate Injection.
The Cisatracurium Besylate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cisatracurium Besylate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cisatracurium Besylate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cisatracurium Besylate Injection Market Report

Report Metric Details
Report Name Cisatracurium Besylate Injection Market
Segment by Type
  • 2 mg/mL
  • 5 mg/mL
  • 10 mg/mL
Segment by Application
  • Hospital
  • Clinics
  • Recovery Center
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Fresenius Kabi, Meitheal Pharmaceuticals, Pfizer, Sandoz, Teva, Shanghai Hengrui Pharmaceutical, Xianju Pharma, Jiangsu Singchn, Shanghai Sino Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cisatracurium Besylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cisatracurium Besylate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cisatracurium Besylate Injection Market report?

Ans: The main players in the Cisatracurium Besylate Injection Market are AbbVie, Fresenius Kabi, Meitheal Pharmaceuticals, Pfizer, Sandoz, Teva, Shanghai Hengrui Pharmaceutical, Xianju Pharma, Jiangsu Singchn, Shanghai Sino Biopharma

What are the Application segmentation covered in the Cisatracurium Besylate Injection Market report?

Ans: The Applications covered in the Cisatracurium Besylate Injection Market report are Hospital, Clinics, Recovery Center

What are the Type segmentation covered in the Cisatracurium Besylate Injection Market report?

Ans: The Types covered in the Cisatracurium Besylate Injection Market report are 2 mg/mL, 5 mg/mL, 10 mg/mL

1 Cisatracurium Besylate Injection Market Overview
1.1 Product Definition
1.2 Cisatracurium Besylate Injection by Type
1.2.1 Global Cisatracurium Besylate Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 2 mg/mL
1.2.3 5 mg/mL
1.2.4 10 mg/mL
1.3 Cisatracurium Besylate Injection by Application
1.3.1 Global Cisatracurium Besylate Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Global Cisatracurium Besylate Injection Market Size Estimates and Forecasts
1.4.1 Global Cisatracurium Besylate Injection Revenue 2020-2031
1.4.2 Global Cisatracurium Besylate Injection Sales 2020-2031
1.4.3 Global Cisatracurium Besylate Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cisatracurium Besylate Injection Market Competition by Manufacturers
2.1 Global Cisatracurium Besylate Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cisatracurium Besylate Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cisatracurium Besylate Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cisatracurium Besylate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cisatracurium Besylate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cisatracurium Besylate Injection, Product Type & Application
2.7 Global Key Manufacturers of Cisatracurium Besylate Injection, Date of Enter into This Industry
2.8 Global Cisatracurium Besylate Injection Market Competitive Situation and Trends
2.8.1 Global Cisatracurium Besylate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cisatracurium Besylate Injection Players Market Share by Revenue
2.8.3 Global Cisatracurium Besylate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cisatracurium Besylate Injection Market Scenario by Region
3.1 Global Cisatracurium Besylate Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cisatracurium Besylate Injection Sales by Region: 2020-2031
3.2.1 Global Cisatracurium Besylate Injection Sales by Region: 2020-2025
3.2.2 Global Cisatracurium Besylate Injection Sales by Region: 2026-2031
3.3 Global Cisatracurium Besylate Injection Revenue by Region: 2020-2031
3.3.1 Global Cisatracurium Besylate Injection Revenue by Region: 2020-2025
3.3.2 Global Cisatracurium Besylate Injection Revenue by Region: 2026-2031
3.4 North America Cisatracurium Besylate Injection Market Facts & Figures by Country
3.4.1 North America Cisatracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cisatracurium Besylate Injection Sales by Country (2020-2031)
3.4.3 North America Cisatracurium Besylate Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cisatracurium Besylate Injection Market Facts & Figures by Country
3.5.1 Europe Cisatracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cisatracurium Besylate Injection Sales by Country (2020-2031)
3.5.3 Europe Cisatracurium Besylate Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cisatracurium Besylate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Cisatracurium Besylate Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cisatracurium Besylate Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Cisatracurium Besylate Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cisatracurium Besylate Injection Market Facts & Figures by Country
3.7.1 Latin America Cisatracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cisatracurium Besylate Injection Sales by Country (2020-2031)
3.7.3 Latin America Cisatracurium Besylate Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cisatracurium Besylate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Cisatracurium Besylate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cisatracurium Besylate Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cisatracurium Besylate Injection Sales by Type (2020-2031)
4.1.1 Global Cisatracurium Besylate Injection Sales by Type (2020-2025)
4.1.2 Global Cisatracurium Besylate Injection Sales by Type (2026-2031)
4.1.3 Global Cisatracurium Besylate Injection Sales Market Share by Type (2020-2031)
4.2 Global Cisatracurium Besylate Injection Revenue by Type (2020-2031)
4.2.1 Global Cisatracurium Besylate Injection Revenue by Type (2020-2025)
4.2.2 Global Cisatracurium Besylate Injection Revenue by Type (2026-2031)
4.2.3 Global Cisatracurium Besylate Injection Revenue Market Share by Type (2020-2031)
4.3 Global Cisatracurium Besylate Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cisatracurium Besylate Injection Sales by Application (2020-2031)
5.1.1 Global Cisatracurium Besylate Injection Sales by Application (2020-2025)
5.1.2 Global Cisatracurium Besylate Injection Sales by Application (2026-2031)
5.1.3 Global Cisatracurium Besylate Injection Sales Market Share by Application (2020-2031)
5.2 Global Cisatracurium Besylate Injection Revenue by Application (2020-2031)
5.2.1 Global Cisatracurium Besylate Injection Revenue by Application (2020-2025)
5.2.2 Global Cisatracurium Besylate Injection Revenue by Application (2026-2031)
5.2.3 Global Cisatracurium Besylate Injection Revenue Market Share by Application (2020-2031)
5.3 Global Cisatracurium Besylate Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Cisatracurium Besylate Injection Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Company Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius Kabi Cisatracurium Besylate Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Meitheal Pharmaceuticals
6.3.1 Meitheal Pharmaceuticals Company Information
6.3.2 Meitheal Pharmaceuticals Description and Business Overview
6.3.3 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Portfolio
6.3.5 Meitheal Pharmaceuticals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Cisatracurium Besylate Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sandoz Cisatracurium Besylate Injection Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Cisatracurium Besylate Injection Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Shanghai Hengrui Pharmaceutical
6.7.1 Shanghai Hengrui Pharmaceutical Company Information
6.7.2 Shanghai Hengrui Pharmaceutical Description and Business Overview
6.7.3 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Portfolio
6.7.5 Shanghai Hengrui Pharmaceutical Recent Developments/Updates
6.8 Xianju Pharma
6.8.1 Xianju Pharma Company Information
6.8.2 Xianju Pharma Description and Business Overview
6.8.3 Xianju Pharma Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Xianju Pharma Cisatracurium Besylate Injection Product Portfolio
6.8.5 Xianju Pharma Recent Developments/Updates
6.9 Jiangsu Singchn
6.9.1 Jiangsu Singchn Company Information
6.9.2 Jiangsu Singchn Description and Business Overview
6.9.3 Jiangsu Singchn Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu Singchn Cisatracurium Besylate Injection Product Portfolio
6.9.5 Jiangsu Singchn Recent Developments/Updates
6.10 Shanghai Sino Biopharma
6.10.1 Shanghai Sino Biopharma Company Information
6.10.2 Shanghai Sino Biopharma Description and Business Overview
6.10.3 Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Portfolio
6.10.5 Shanghai Sino Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cisatracurium Besylate Injection Industry Chain Analysis
7.2 Cisatracurium Besylate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cisatracurium Besylate Injection Production Mode & Process Analysis
7.4 Cisatracurium Besylate Injection Sales and Marketing
7.4.1 Cisatracurium Besylate Injection Sales Channels
7.4.2 Cisatracurium Besylate Injection Distributors
7.5 Cisatracurium Besylate Injection Customer Analysis
8 Cisatracurium Besylate Injection Market Dynamics
8.1 Cisatracurium Besylate Injection Industry Trends
8.2 Cisatracurium Besylate Injection Market Drivers
8.3 Cisatracurium Besylate Injection Market Challenges
8.4 Cisatracurium Besylate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Fresenius Kabi
Meitheal Pharmaceuticals
Pfizer Inc
Sandoz Inc
TEVA
Shanghai Hengrui Pharmaceutical
XIANJU PHARMA
Jiangsu Singchn
Shanghai Sino Biopharma
List of Tables
 Table 1. Global Cisatracurium Besylate Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cisatracurium Besylate Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cisatracurium Besylate Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cisatracurium Besylate Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cisatracurium Besylate Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cisatracurium Besylate Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cisatracurium Besylate Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cisatracurium Besylate Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cisatracurium Besylate Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cisatracurium Besylate Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cisatracurium Besylate Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Cisatracurium Besylate Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cisatracurium Besylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisatracurium Besylate Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cisatracurium Besylate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cisatracurium Besylate Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cisatracurium Besylate Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Cisatracurium Besylate Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cisatracurium Besylate Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Cisatracurium Besylate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cisatracurium Besylate Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Cisatracurium Besylate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cisatracurium Besylate Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Cisatracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cisatracurium Besylate Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cisatracurium Besylate Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cisatracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cisatracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cisatracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cisatracurium Besylate Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cisatracurium Besylate Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cisatracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cisatracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cisatracurium Besylate Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cisatracurium Besylate Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cisatracurium Besylate Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cisatracurium Besylate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cisatracurium Besylate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cisatracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cisatracurium Besylate Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cisatracurium Besylate Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cisatracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cisatracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cisatracurium Besylate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cisatracurium Besylate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cisatracurium Besylate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cisatracurium Besylate Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Cisatracurium Besylate Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Cisatracurium Besylate Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Cisatracurium Besylate Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Cisatracurium Besylate Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cisatracurium Besylate Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cisatracurium Besylate Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Cisatracurium Besylate Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Cisatracurium Besylate Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Cisatracurium Besylate Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Cisatracurium Besylate Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Cisatracurium Besylate Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Cisatracurium Besylate Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Cisatracurium Besylate Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Cisatracurium Besylate Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cisatracurium Besylate Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cisatracurium Besylate Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Cisatracurium Besylate Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Cisatracurium Besylate Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Cisatracurium Besylate Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Cisatracurium Besylate Injection Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Fresenius Kabi Company Information
 Table 76. Fresenius Kabi Description and Business Overview
 Table 77. Fresenius Kabi Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Fresenius Kabi Cisatracurium Besylate Injection Product
 Table 79. Fresenius Kabi Recent Developments/Updates
 Table 80. Meitheal Pharmaceuticals Company Information
 Table 81. Meitheal Pharmaceuticals Description and Business Overview
 Table 82. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product
 Table 84. Meitheal Pharmaceuticals Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Cisatracurium Besylate Injection Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Sandoz Company Information
 Table 91. Sandoz Description and Business Overview
 Table 92. Sandoz Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sandoz Cisatracurium Besylate Injection Product
 Table 94. Sandoz Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Cisatracurium Besylate Injection Product
 Table 99. Teva Recent Developments/Updates
 Table 100. Shanghai Hengrui Pharmaceutical Company Information
 Table 101. Shanghai Hengrui Pharmaceutical Description and Business Overview
 Table 102. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product
 Table 104. Shanghai Hengrui Pharmaceutical Recent Developments/Updates
 Table 105. Xianju Pharma Company Information
 Table 106. Xianju Pharma Description and Business Overview
 Table 107. Xianju Pharma Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Xianju Pharma Cisatracurium Besylate Injection Product
 Table 109. Xianju Pharma Recent Developments/Updates
 Table 110. Jiangsu Singchn Company Information
 Table 111. Jiangsu Singchn Description and Business Overview
 Table 112. Jiangsu Singchn Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Jiangsu Singchn Cisatracurium Besylate Injection Product
 Table 114. Jiangsu Singchn Recent Developments/Updates
 Table 115. Shanghai Sino Biopharma Company Information
 Table 116. Shanghai Sino Biopharma Description and Business Overview
 Table 117. Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai Sino Biopharma Cisatracurium Besylate Injection Product
 Table 119. Shanghai Sino Biopharma Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Cisatracurium Besylate Injection Distributors List
 Table 123. Cisatracurium Besylate Injection Customers List
 Table 124. Cisatracurium Besylate Injection Market Trends
 Table 125. Cisatracurium Besylate Injection Market Drivers
 Table 126. Cisatracurium Besylate Injection Market Challenges
 Table 127. Cisatracurium Besylate Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cisatracurium Besylate Injection
 Figure 2. Global Cisatracurium Besylate Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cisatracurium Besylate Injection Market Share by Type: 2024 & 2031
 Figure 4. 2 mg/mL Product Picture
 Figure 5. 5 mg/mL Product Picture
 Figure 6. 10 mg/mL Product Picture
 Figure 7. Global Cisatracurium Besylate Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cisatracurium Besylate Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinics
 Figure 11. Recovery Center
 Figure 12. Global Cisatracurium Besylate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Cisatracurium Besylate Injection Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Cisatracurium Besylate Injection Sales (2020-2031) & (K Units)
 Figure 15. Global Cisatracurium Besylate Injection Average Price (US$/Unit) & (2020-2031)
 Figure 16. Cisatracurium Besylate Injection Report Years Considered
 Figure 17. Cisatracurium Besylate Injection Sales Share by Manufacturers in 2024
 Figure 18. Global Cisatracurium Besylate Injection Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Cisatracurium Besylate Injection Players: Market Share by Revenue in Cisatracurium Besylate Injection in 2024
 Figure 20. Cisatracurium Besylate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Cisatracurium Besylate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Cisatracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 23. North America Cisatracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Cisatracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 27. Europe Cisatracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Cisatracurium Besylate Injection Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Cisatracurium Besylate Injection Revenue Market Share by Region (2020-2031)
 Figure 35. China Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Cisatracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Cisatracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Cisatracurium Besylate Injection Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Cisatracurium Besylate Injection Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Cisatracurium Besylate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Cisatracurium Besylate Injection by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Cisatracurium Besylate Injection by Type (2020-2031)
 Figure 57. Global Cisatracurium Besylate Injection Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Cisatracurium Besylate Injection by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Cisatracurium Besylate Injection by Application (2020-2031)
 Figure 60. Global Cisatracurium Besylate Injection Price (US$/Unit) by Application (2020-2031)
 Figure 61. Cisatracurium Besylate Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Cisatracurium Besylate Market Research Report 2024
Cisatracurium Besylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atracurium Besylate Injection Market Research Report 2025
Global Cisatracurium Besilate Injection Market Research Report 2024
Global Atracurium Besylate API Market Research Report 2025
Atracurium Besylate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Skeletal Muscular Relaxants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vecuronium Bromide Injection Market Research Report 2024
Global Rocuronium Injection Market Research Report 2024
Global Skeletal Muscle Relaxants Market Research Report 2025
Global Atropine Sulfate for Injection Market Research Report 2024
Muscle Spasm Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rocuronium Bromide Injection Market Research Report 2024
Muscle Spasm Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Etomidate Injection Market Research Report 2024
Global Intramuscular Drug Delivery Market
Global Rocuronium Bromide API Market Research Report 2024
Global Remimazolam Besylate for Injection Market Research Report 2024
Global Atropine Sulfate Injection Market Research Report 2024
Muscle Relaxants Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions